887576-33-2 Usage
Uses
Used in Pharmaceutical Industry:
4-(N-Morpholino)-N-methyl-N-methoxybenzamide is used as a synthetic intermediate for the preparation of pharmaceuticals, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
4-(N-MORPHOLINO)-N-METHY-N-METHOXYBENZAMIDE is also used as a synthetic intermediate in the preparation of agrochemicals, playing a role in the development of new products for agricultural applications.
Used in Organic Synthesis:
4-(N-Morpholino)-N-methyl-N-methoxybenzamide serves as a reagent in organic synthesis, facilitating the creation of various organic compounds for research and industrial purposes.
Used in Heterocyclic Compound Synthesis:
As a building block, 4-(N-MORPHOLINO)-N-METHY-N-METHOXYBENZAMIDE is utilized in the synthesis of various heterocyclic compounds, which are important in the fields of chemistry and material science.
Used in Drug Development and Research:
Due to its water solubility and enhanced bioavailability, 4-(N-Morpholino)-N-methyl-N-methoxybenzamide is a valuable component in drug development and research, potentially leading to the discovery of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 887576-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,5,7 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 887576-33:
(8*8)+(7*8)+(6*7)+(5*5)+(4*7)+(3*6)+(2*3)+(1*3)=242
242 % 10 = 2
So 887576-33-2 is a valid CAS Registry Number.
InChI:InChI=1/C13H18N2O3/c1-14(17-2)13(16)11-3-5-12(6-4-11)15-7-9-18-10-8-15/h3-6H,7-10H2,1-2H3
887576-33-2Relevant academic research and scientific papers
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
-
, (2022/03/22)
The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).
Iron-Catalyzed, Iminyl Radical-Triggered Cascade 1,5-Hydrogen Atom Transfer/(5+2) or (5+1) Annulation: Oxime as a Five-Atom Assembling Unit
Chen, Ying-Chun,Du, Fei,Jiang, Kun,Liang, Wu,Ouyang, Qin,Shuai, Li,Wei, Ye,Yang, Jie
supporting information, p. 19222 - 19228 (2020/08/25)
By integration of iminyl radical-triggered 1,5-hydrogen atom transfer and (5+2) or (5+1) annulation processes, a series of structurally novel and interesting azepine and spiro-tetrahydropyridine derivatives have been successfully prepared in moderate to good yields. This method utilizes FeCl2 as the catalyst and readily available oximes as five-atom units, while showcasing broad substrate scope and good functional group compatibility. The annulation products can be easily converted into many valuable compounds. Moreover, DFT calculation studies are performed to provide some insights into the possible reaction mechanisms for the (5+2) and (5+1) annulations.
